Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

18.2%

2 terminated/withdrawn out of 11 trials

Success Rate

81.8%

-4.7% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

33%

3 of 9 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

N/A

4(44.4%)

Phase 2

3(33.3%)

Phase 1

2(22.2%)

9Total

N/A(4)

Phase 2(3)

Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (11)

Showing 11 of 11 trials

NCT04683640Phase 2Completed

Latent Aging Mechanisms in Pain and Sleep

Role: collaborator

NCT04565145Phase 2Completed

Biomarker Changes and Anxiolytic Effects-Phase 2

Role: collaborator

NCT03843502Phase 1Completed

A Phased Clinical Trial of Dietary Supplemental Kava: Kava Pharmacokinetics

Role: collaborator

NCT05297032Not ApplicableTerminated

Effects of Quercetin on Metabolic Health

Role: lead

NCT05041192Not ApplicableCompleted

The Effects of Synaquell on Brain Function

Role: collaborator

NCT05381025Not ApplicableCompleted

Kavalactones on Sleep and Cortisol in Healthy Special Forces Trainees

Role: lead

NCT02721537Not ApplicableCompleted

Use of 31P MRS to Assess Brain NAD+ in Healthy Current and Former Collegiate Athletes

Role: collaborator

NCT04109742Phase 2Withdrawn

Curcumin for Pediatric Nonalcoholic Fatty Liver Disease

Role: collaborator

NCT02663479Phase 1Completed

Nutraceutical Supplement in the Management of Hypertension

Role: lead

NCT04026672Completed

Hemp Oil + User Experience Study

Role: lead

NCT02818413Completed

Stool Microbiome, Pathogens, and Infectious Agents Among Olympic and Elite Athletes

Role: collaborator

All 11 trials loaded